Grant R. Campbell

9.1k total citations
42 papers, 1.8k citations indexed

About

Grant R. Campbell is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Grant R. Campbell has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Virology, 21 papers in Immunology and 15 papers in Epidemiology. Recurrent topics in Grant R. Campbell's work include HIV Research and Treatment (33 papers), Immune Cell Function and Interaction (10 papers) and Autophagy in Disease and Therapy (9 papers). Grant R. Campbell is often cited by papers focused on HIV Research and Treatment (33 papers), Immune Cell Function and Interaction (10 papers) and Autophagy in Disease and Therapy (9 papers). Grant R. Campbell collaborates with scholars based in United States, France and Uganda. Grant R. Campbell's co-authors include Stephen A. Spector, Erwann Loret, Jennifer Watkins, Pratima Rawat, Didier Esquieu, Gang Zhang, Sandrine Opi, David Yirrell, Liangfang Zhang and Rodney Trout and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Virology.

In The Last Decade

Grant R. Campbell

42 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grant R. Campbell United States 24 910 618 604 531 478 42 1.8k
Yan Xu China 29 1.1k 1.2× 762 1.2× 578 1.0× 1.1k 2.1× 651 1.4× 101 2.7k
Roberto Mariani United States 21 1.9k 2.1× 649 1.1× 735 1.2× 1.1k 2.0× 919 1.9× 28 2.8k
Gary J. Nabel United States 14 645 0.7× 801 1.3× 469 0.8× 1.1k 2.2× 581 1.2× 18 2.5k
Núria Climent Spain 22 581 0.6× 545 0.9× 329 0.5× 843 1.6× 282 0.6× 54 1.9k
Jean‐Philippe Herbeuval France 23 835 0.9× 390 0.6× 382 0.6× 1.5k 2.9× 307 0.6× 55 2.3k
Christian Körner Germany 29 206 0.2× 700 1.1× 524 0.9× 1.1k 2.0× 159 0.3× 52 2.2k
Zhuang Li China 24 616 0.7× 356 0.6× 444 0.7× 481 0.9× 541 1.1× 79 1.5k
Anna George India 26 135 0.1× 499 0.8× 292 0.5× 1.2k 2.2× 330 0.7× 98 2.1k
Ezequiel Ruíz-Mateos Spain 27 1.4k 1.6× 398 0.6× 555 0.9× 940 1.8× 863 1.8× 119 2.4k
David Favre United States 18 894 1.0× 791 1.3× 419 0.7× 838 1.6× 481 1.0× 23 2.2k

Countries citing papers authored by Grant R. Campbell

Since Specialization
Citations

This map shows the geographic impact of Grant R. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant R. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant R. Campbell more than expected).

Fields of papers citing papers by Grant R. Campbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant R. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant R. Campbell. The network helps show where Grant R. Campbell may publish in the future.

Co-authorship network of co-authors of Grant R. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Grant R. Campbell. A scholar is included among the top collaborators of Grant R. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant R. Campbell. Grant R. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campbell, Grant R., Pratima Rawat, Carmen Teodorof‐Diedrich, & Stephen A. Spector. (2023). IRAK1 inhibition blocks the HIV-1 RNA mediated pro-inflammatory cytokine response from microglia. Journal of General Virology. 104(5). 2 indexed citations
2.
Campbell, Grant R., et al.. (2023). HIV-1 Tat Upregulates TREM1 Expression in Human Microglia. The Journal of Immunology. 211(3). 429–442. 7 indexed citations
3.
Tencer, Adam H., Sébastien Causse, Grant R. Campbell, et al.. (2023). Molecular basis for nuclear accumulation and targeting of the inhibitor of apoptosis BIRC2. Nature Structural & Molecular Biology. 30(9). 1265–1274. 2 indexed citations
4.
Campbell, Grant R., et al.. (2020). SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected macrophages. Cell Death and Disease. 11(7). 590–590. 28 indexed citations
5.
Zhang, Gang, Brian T. Luk, Xiaoli Wei, et al.. (2019). Selective cell death of latently HIV-infected CD4+ T cells mediated by autosis inducing nanopeptides. Cell Death and Disease. 10(6). 419–419. 38 indexed citations
6.
Campbell, Grant R., et al.. (2014). Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1. Journal of Biological Chemistry. 290(8). 5028–5040. 56 indexed citations
7.
Campbell, Grant R., et al.. (2013). Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion. AIDS. 27(9). 1397–1401. 6 indexed citations
8.
Campbell, Grant R. & Stephen A. Spector. (2012). Vitamin D Inhibits Human Immunodeficiency Virus Type 1 and Mycobacterium tuberculosis Infection in Macrophages through the Induction of Autophagy. PLoS Pathogens. 8(5). e1002689–e1002689. 231 indexed citations
9.
Campbell, Grant R., Jennifer Watkins, Erwann Loret, & Stephen A. Spector. (2010). Differential Induction of Rat Neuronal Excitotoxic Cell Death by Human Immunodeficiency Virus Type 1 Clade B and C Tat Proteins. AIDS Research and Human Retroviruses. 27(6). 647–654. 23 indexed citations
10.
Campbell, Grant R., et al.. (2010). Differential Induction of Interleukin-10 in Monocytes by HIV-1 Clade B and Clade C Tat Proteins. Journal of Biological Chemistry. 285(24). 18319–18325. 33 indexed citations
11.
Shafer, Leigh Anne, Grant R. Campbell, Erwann Loret, et al.. (2008). Tat-Specific Binding IgG and Disease Progression in HIV Type 1-Infected Ugandans. AIDS Research and Human Retroviruses. 24(4). 587–594. 11 indexed citations
12.
Campbell, Grant R. & Stephen A. Spector. (2008). CCL2 Increases X4-tropic HIV-1 Entry into Resting CD4+ T Cells. Journal of Biological Chemistry. 283(45). 30745–30753. 42 indexed citations
13.
Watkins, Jennifer, Sophie Lancelot, Grant R. Campbell, et al.. (2006). Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. Retrovirology. 3(1). 8–8. 22 indexed citations
14.
Campbell, Grant R., Jennifer Watkins, Didier Esquieu, et al.. (2005). The C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T Cells. Journal of Biological Chemistry. 280(46). 38376–38382. 35 indexed citations
15.
Carré, Manon, Pascale Barbier, Grant R. Campbell, et al.. (2005). HIV-1 Tat protein enhances Microtubule polymerization. Retrovirology. 2(1). 5–5. 48 indexed citations
16.
Opi, Sandrine, Jean‐Marie Péloponèse, Didier Esquieu, et al.. (2004). Full-length HIV-1 Tat protein necessary for a vaccine. Vaccine. 22(23-24). 3105–3111. 22 indexed citations
17.
Esquieu, Didier, Jean‐Marie Péloponèse, Sandrine Opi, et al.. (2003). Discovery of a Tat HIV‐1 Inhibitor through Computer‐Aided Drug Design. Journal of Spectroscopy. 17(4). 639–645. 6 indexed citations
18.
Opi, Sandrine, Jean‐Marie Péloponèse, Didier Esquieu, et al.. (2002). Tat HIV-1 Primary and Tertiary Structures Critical to Immune Response Against Non-homologous Variants. Journal of Biological Chemistry. 277(39). 35915–35919. 34 indexed citations
19.
Grégoire, Catherine, Jean‐Marie Péloponèse, Didier Esquieu, et al.. (2001). Homonuclear 1H‐NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Biopolymers. 62(6). 324–335. 42 indexed citations
20.
Campbell, Grant R., et al.. (1990). Molecular biology of atherosclerosis. 12. 52–56. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Xu Breakdown of academic impact, for papers by Roberto Mariani Breakdown of academic impact, for papers by Gary J. Nabel Breakdown of academic impact, for papers by Núria Climent Breakdown of academic impact, for papers by Jean‐Philippe Herbeuval Breakdown of academic impact, for papers by Christian Körner Breakdown of academic impact, for papers by Zhuang Li Breakdown of academic impact, for papers by Anna George Breakdown of academic impact, for papers by Ezequiel Ruíz-Mateos Breakdown of academic impact, for papers by David Favre
Rankless by CCL
2026